Abstract:Parenteral Nutrition (PN) provides essential caloric support in patients unable to feed enterally. Unfortunately, PN without enteral feeding is associated with hepatic injury, especially in neonates where PN associated liver disease (PNALD) affects 60–70% of recipients. PN alters intestinal physiology and host‐microbial interactions, including bile acid enterohepatic circulation, which regulates metabolism through nuclear and cell membrane bile acid receptors. Here, we examined the role of G‐protein coupled bile acid receptor deficiency (TGR5−/−) upon hepatic phenotype in a murine model of acute PN. TGR5−/− and wild type (WT) received PN for 96 hours. PN significantly elevated serum triglycerides, resistin, PAI‐1 and hepatic fatty acid synthesis gene expression in both genotypes. However, PN‐treated TGR5−/− animals had significantly larger liver weights compared with WT, but displayed no changes in triglycerides. Histological analysis instead suggested edema. Accordingly, TGR5−/− animals on PN displayed elevated hepatic IL‐6 expression and significantly higher serum AST and ALT levels compared with WT. Furthermore, TGR5−/− animals on PN also displayed significantly decreased bile acid synthesis genes, including Cyp7A1, Cyp8B1, Cyp7B1, and BAT, compared with WT. Therefore, we examined serum bile acid composition. PN elevated total conjugated primary bile acid levels, specifically TCA, TCDCA, TbMCA, and TaMCA, in both genotypes compared with chow. However, TGR5−/− on PN displayed markedly higher levels of the unconjugated primary bile acids, CDCA, aMCA, and the secondary bile acids, oMCA and DCA, compared with WT on PN. Predictive metagenomics of 16S sequencing suggested altered microbial enzymes in TGR5−/−, including BSH and 7alpha hydroxylase, consistent with serum bile acid changes. These results suggest a protective role for TGR5 in liver function during PN that potentially includes direct attenuation of hepatic inflammation or indirect manipulation through microbiota‐bile acid interactions. Greater mechanistic understanding of TGR5 signaling during PN might improve interventions to treat or prevent PNALD. This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Liver PP2A-Cα Protects From Parenteral Nutrition-associated Hepatic Steatosis

Lactobacillus Johnsonii Attenuates Liver Steatosis and Bile Acid Dysregulation in Parenteral Nutrition-Fed Rats.

Peroxisome Proliferator-Activated Receptor Γ Coactivator 1α Maintains NAD+ Bioavailability Protecting Against Steatohepatitis

Niacin Ameliorates Hepatic Steatosis by Inhibiting De Novo Lipogenesis Via a GPR109A-Mediated PKC-ERK1/2-AMPK Signaling Pathway in C57BL/6 Mice Fed a High-Fat Diet

Proteome Characteristics of Liver Tissue from Patients with Parenteral Nutrition-Associated Liver Disease

N-3 Polyunsaturated Fatty Acids Ameliorate Hepatic Steatosis Via the PPAR-α/CPT-1α Pathway in a Mouse Model of Parenteral Nutrition

G‐protein‐Coupled Bile Acid Receptor Attenuates Liver Injury in a Murine Model of Acute Parenteral Nutrition

Perturbation of Specific Signaling Pathways Is Involved in Initiation of Mouse Liver Fibrosis

ASPP2 attenuates triglycerides to protect against hepatocyte injury by reducing autophagy in a cell and mouse model of non-alcoholic fatty liver disease

Protein phosphatase 2A regulates cytotoxicity and drug resistance by dephosphorylating xenobiotic metabolism enzymes AHR and MDR1

Liver-specific deletion of Ppp2c alpha enhances glucose metabolism and insulin sensitivity

PP2Acα Positively Regulates the Termination of Liver Regeneration in Mice Through the AKT/GSK3β/Cyclin D1 Pathway.

Liver-specific deletion of Ppp2cα enhances glucose metabolism and insulin sensitivity.

A Role for Intestinal Alkaline Phosphatase in Preventing Liver Fibrosis

PGC1α protects against hepatic steatosis and insulin resistance via enhancing IL10-mediated anti-inflammatory response.

PNPLA3(148M) Promotes Hepatic Steatosis by Interfering with Triglyceride Hydrolysis Through a Gain-of-Function Mechanism

Differential Metabolomic Analysis of Liver Tissues from Rat Models of Parenteral Nutrition-Associated Liver Disease

Pien Tze Huang Protects Against Non-Alcoholic Steatohepatitis by Modulating the Gut Microbiota and Metabolites in Mice

PNPLA3, CGI‐58, and Inhibition of Hepatic Triglyceride Hydrolysis in Mice

P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice

ASPP2 Deficiency Attenuates Lipid Accumulation Through the PPARγ Pathway in Alcoholic Liver Injury